Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Proximal myotonic myopathy

ORPHA606
Synonym(s) Myotonic dystrophy type 2
Proximal myotonic dystrophy
Ricker disease
Ricker syndrome
Prevalence 1-9 / 100 000
Inheritance Autosomal dominant
Age of onset Adult
ICD-10
  • G71.1
OMIM
UMLS
  • C0752354
MeSH
  • D020967
MedDRA -

Summary

Proximal myotonic myopathy is a multisystemic disease characterised by the association of proximal muscle weakness with myotonia, cardiac manifestations and cataract. Prevalence is estimated at around 1 in 100,000 but precise values are not yet available. The disease appears to be more prevalent in Germany and the USA, suggesting a founder effect originating from North European families. Patients usually present during adulthood (between 40 and 50 years of age). There are no reports of congenital or childhood onset but a rare juvenile form of the disease has been described. Expression is variable and is characterised by: 1) a proximal motor deficit (involving the pelvic and scapular girdles) associated with frequent myalgia which is often indicative of the diagnosis (myotonia is reported in 75% of cases and involvement of the facial muscles is rare, occurring in only 12% of patients); 2) tremors that are present in between 20 and 30% of cases; 3) cardiac manifestations with arrhythmia and conduction anomalies, and in some cases cardiomyopathy, making cardiac monitoring necessary in all patients; 4) posterior capsular opacification; 5) endocrinal anomalies with hyperhidrosis, testicular atrophy, insulin resistance and diabetes; 6) in rare cases, central nervous system anomalies (visuospatial defects); 7) biochemical anomalies (hypogammaglobulinemia, cholestasis). The disease is transmitted in an autosomal dominant manner and is caused by expansion of a CCTG repeat in intron 1 of the CNBP gene (3q21). Anticipation has been reported in some families but is not a constant feature. There is no correlation between the number of CCTG repeats and the age of onset of the disease. Molecular diagnosis relies on PCR and Southern blot analysis. Proximal myotonic myopathy can be distinguished from Steinert myotonic dystrophy (see this term) by the following criteria: 1) absence of a congenital form; 2) only minimal involvement of the central nervous system (absence of hypersomnia); 3) the topography of the motor deficit: proximal deficiency without facial or bulbar involvement; 4) frequent myalgia; and 5) less severe cardiac involvement. Management and follow up should be multidisciplinary and cardiac monitoring is recommended. Several therapeutic approaches are currently being investigated in model cell systems. The prognosis depends on the extent of the cardiac involvement. The respiratory insufficiency is rarely severe. The ability to walk is often retained until 60 years of age.

Expert reviewer(s)

  • Dr Françoise BOUHOUR

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Clinical practice guidelines
  • DE (2012)
  • EN (2012)
Article for general public
  • FR (2008)
  • EN (2013)
Clinical genetics review
  • EN (2013)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.